The UK pharmaceutical industry is facing an unprecedented challenge. Pharmaceutical companies across the nation have seen declining profits, increased regulation, and a drop in R&D investment. This has led to an uncertain outlook for the industry as it struggles with shifting economics and supply chain challenges. The recent Brexit vote has only further added to the anxiousness. Innovative...